These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 22542938)
1. Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration. Liang Y; Liu Z; Shuai X; Wang W; Liu J; Bi W; Wang C; Jing X; Liu Y; Tao E Biochem Biophys Res Commun; 2012 May; 421(4):690-5. PubMed ID: 22542938 [TBL] [Abstract][Full Text] [Related]
2. The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro. Wu Y; Wang W; Chen Y; Huang K; Shuai X; Chen Q; Li X; Lian G Int J Nanomedicine; 2010 Mar; 5():129-36. PubMed ID: 20309399 [TBL] [Abstract][Full Text] [Related]
3. Investigation of the performance of PEG-PEI/ROCK-II-siRNA complexes for Alzheimer's disease in vitro. Liu Y; Liu Z; Wang Y; Liang YR; Wen X; Hu J; Yang X; Liu J; Xiao S; Cheng D Brain Res; 2013 Jan; 1490():43-51. PubMed ID: 23103413 [TBL] [Abstract][Full Text] [Related]
4. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy. Li TS; Yawata T; Honke K Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005 [TBL] [Abstract][Full Text] [Related]
5. Characterization of polyethylene glycol-polyethyleneimine as a vector for alpha-synuclein siRNA delivery to PC12 cells for Parkinson's disease. Liu YY; Yang XY; Li Z; Liu ZL; Cheng D; Wang Y; Wen XJ; Hu JY; Liu J; Wang LM; Wang HJ CNS Neurosci Ther; 2014 Jan; 20(1):76-85. PubMed ID: 24279586 [TBL] [Abstract][Full Text] [Related]
6. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo. Chen Y; Lian G; Liao C; Wang W; Zeng L; Qian C; Huang K; Shuai X J Gastroenterol; 2013 Jul; 48(7):809-21. PubMed ID: 23179610 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro. Nie C; Liu C; Chen G; Dai J; Li H; Shuai X J Biomater Appl; 2011 Sep; 26(3):255-75. PubMed ID: 20511388 [TBL] [Abstract][Full Text] [Related]
8. Polyelectrolyte complexes of hTERT siRNA and polyethyleneimine: Effect of degree of PEG grafting on biological and cellular activity. Safari F; Tamaddon AM; Zarghami N; Abolmali S; Akbarzadeh A Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1561-8. PubMed ID: 26232080 [TBL] [Abstract][Full Text] [Related]
9. Polymer nanoassemblies with hydrophobic pendant groups in the core induce false positive siRNA transfection in luciferase reporter assays. Rheiner S; Reichel D; Rychahou P; Izumi T; Yang HS; Bae Y Int J Pharm; 2017 Aug; 528(1-2):536-546. PubMed ID: 28629980 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA. Kim N; Jiang D; Jacobi AM; Lennox KA; Rose SD; Behlke MA; Salem AK Int J Pharm; 2012 May; 427(1):123-33. PubMed ID: 21864664 [TBL] [Abstract][Full Text] [Related]
11. Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery. Lei Y; Wang J; Xie C; Wagner E; Lu W; Li Y; Wei X; Dong J; Liu M J Gene Med; 2013; 15(8-9):291-305. PubMed ID: 24038955 [TBL] [Abstract][Full Text] [Related]
12. Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy. Lu ZX; Liu LT; Qi XR Int J Nanomedicine; 2011; 6():1661-73. PubMed ID: 21904456 [TBL] [Abstract][Full Text] [Related]
13. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol). Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134 [TBL] [Abstract][Full Text] [Related]
14. Lyophilised ready-to-use formulations of PEG-PCL-PEI nano-carriers for siRNA delivery. Endres T; Zheng M; Beck-Broichsitter M; Kissel T Int J Pharm; 2012 May; 428(1-2):121-4. PubMed ID: 22414387 [TBL] [Abstract][Full Text] [Related]
15. Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491 [TBL] [Abstract][Full Text] [Related]
16. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer. Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492 [TBL] [Abstract][Full Text] [Related]
17. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance. Merkel OM; Beyerle A; Librizzi D; Pfestroff A; Behr TM; Sproat B; Barth PJ; Kissel T Mol Pharm; 2009; 6(4):1246-60. PubMed ID: 19606864 [TBL] [Abstract][Full Text] [Related]
18. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes. Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390 [TBL] [Abstract][Full Text] [Related]
19. Design of polyethylene glycol-polyethylenimine nanocomplexes as non-viral carriers: mir-150 delivery to chronic myeloid leukemia cells. Biray Avcı Ç; Özcan İ; Balcı T; Özer Ö; Gündüz C Cell Biol Int; 2013 Nov; 37(11):1205-14. PubMed ID: 23881828 [TBL] [Abstract][Full Text] [Related]
20. [Small interfering RNA delivery mediated by mPEG-PCL-g-PEI polymer nanoparticles]. Huang W; Lü M; Gao ZG; Jin MJ; Yang CQ Yao Xue Xue Bao; 2011 Mar; 46(3):344-9. PubMed ID: 21626792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]